Objective: To compare the dosimetric data between preoperative plans and postoperative verification in computed tomography CT-guided and 3D printing template-assisted 125-iodine ((125)I) seed implantation for thorax movement tumor and to explore the feasibility and accuracy of the individualized template design method. Methods: A total of 35 patients, 20 males and 15 females with median age of 62 (17-87) years old, who registered from January 2016 to December 2017 applied with 3D printing guided template assisted radioactive seed implantations in Peking University Third Hospital were included in this study. (125)I seeds with a prescribed dose of 110-180 Gy were impanted. 3D printing templates were designed and produced for 35 cases. The dosimetric parameters: D(90), minimum peripheral dose (mPD), V(100), V(150), V(200), conformal index (CI), external index (EI), and homogeneity index (HI) were compared between pre-and post-plannings. Statistical method was two group of related non-parameters test. Results: The design and production of 35 cases' templates were in place well. Compared with the preoperative planning, the postoperative D(90), V(100), V(150), V(200), mPD, CI, EI and HI differences were 5.57%, 0.34%, 0.33%, -1.20%, 21%, 2.8%, -14.2%, 4.71%, -10.4%. All the included dosimetry parameters changed slightly after surgery compared with before surgery, but the difference was not statistically significant(all P>0.05). Conclusions: The dosimetric parameters of postoperative verification are consistent well with the preoperative planning and have good accuracy, the results could meet the clinical requirements.
目的: 对比3D打印模板引导(125)I粒子植入治疗胸部肿瘤的术前计划与术后计划的剂量学结果,探索一种适用于胸部运动器官粒子植入治疗个体化模板设计方法的可行性、精确性。 方法: 2016年1月至2017年12月于北京大学第三医院接受3D打印模板引导粒子植入的胸部肿瘤患者35例,男20例、女15例,中位年龄62(17~87)岁。处方剂量110~180 Gy,设计制作3D打印模板35块,对比术前、术后剂量学参数,包括90%的靶区体积受照剂量(D(90))、最小周边剂量(mPD)、100%的处方剂量所占体积(V(100))、V(150)、V(200)、适形指数(CI)、靶区外体积指数(EI)、均匀性指数(HI)。统计学采用非参数相关样本检验。 结果: 本研究设计、制作的30例导板术中复位良好,与术前计划相比,术后病灶体积、D(90)、V(100)、V(150)、V(200)、mPD、CI、EI及HI差异分别是5.57%、0.34%、0.33%、-1.20%、21%、2.8%、-14.2%、4.71%、-10.4%。所有纳入的各剂量学参数术后较术前略有变化,但差异均无统计学意义(均P>0.05)。 结论: 术后验证的剂量学指标较好地达到了术前计划要求,有良好的治疗精确性,其结果能较好地满足临床需求。.
Keywords: Radiotherapy dosage; Radiotherapy, computer-assisted; Thoracic neoplasms.